# Sevelamer in Proteinuric CKD

> **NCT01968759** · PHASE2 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 53 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Sevelamer
- **DRUG:** Ramipril and Irbesartan

## Key facts

- **NCT ID:** NCT01968759
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2015-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01968759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01968759, "Sevelamer in Proteinuric CKD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01968759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*